Our current pick
SnoreRX offers micro-adjustable mandibular advancement in 1 mm increments, addressing the patient-selection issue documented in a 2025 institutional outcomes analysis. A 2024 RCT comparing two MAD designs found that adjustability improved both efficacy and compliance. While no long-term data exists specifically on SnoreRX, the 10-year adherence study showed custom-titratable devices achieve 68% long-term use, versus 42% for fixed-position appliances. The evidence does not support the $60 price premium over simpler designs for every user, but adjustability matters if you have variable symptoms or want to minimize side effects through precise titration.
How we evaluated mandibular advancement devices for snoring
We scored each mandibular advancement device for snoring on three dimensions: evidence strength (meta-analyses and RCTs documenting snoring reduction), long-term adherence (the 10-year data shows titratable devices retain 68% of users versus 42% for fixed-position models), and documented side-effect profile (the 2022 meta-analysis covering 36 studies found dental and skeletal changes occur with extended use). 8 2
Adjustability proved decisive. The 2025 predictors study found that inability to titrate mandibular advancement to the minimum effective protrusion correlated with both treatment failure and higher side-effect burden. A 2024 RCT comparing two different MAD designs confirmed that devices permitting incremental adjustment showed superior compliance and efficacy outcomes. 7 4
All 1 finalists, compared
| Product | HP % | Course | Evidence | Sensitivity | Price | Buy |
|---|---|---|---|---|---|---|
| SnoreRX ★ Editor's pick | Micro-adjustable MAD | Nightly | Moderate | Moderate | $60 | Where to buy → |
Evidence rating reflects independent trial support for the product's concentration and protocol, not manufacturer studies. Scroll table sideways on small screens.
The 1 we recommend
SnoreRX offers micro-adjustable mandibular advancement in 1 mm increments, addressing the patient-selection issue documented in a 2025 institutional outcomes analysis. A 2024 RCT comparing two MAD designs found that adjustability improved both efficacy and compliance. While no long-term data exists specifically on SnoreRX, the 10-year adherence study showed custom-titratable devices achieve 68% long-term use, versus 42% for fixed-position appliances. The evidence does not support the $60 price premium over simpler designs for every user, but adjustability matters if you have variable symptoms or want to minimize side effects through precise titration.
Where to buy →Skip these
3 of the 1 kits we reviewed performed poorly enough, on evidence, value, or sensitivity, that we recommend against them regardless of price.
If strips aren't right for you
Strips suit most people, but not everyone. Depending on your situation:
Sources
- Beri A, et al. Appliances Therapy in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis. Cureus. 2023. Cureus 2023 PubMed
- Tsolakis IA, et al. Dental and Skeletal Side Effects of Oral Appliances Used for the Treatment of Obstructive Sleep Apnea and Snoring in Adult Patients. J Pers Med. 2022. J Pers Med 2022 PubMed
- Ioerger P, et al. Mandibular Advancement vs Combined Airway and Positional Therapy for Snoring: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2024. JAMA Otolaryngol Head Neck Surg 2024 PubMed
- Yu L, et al. Clinical study of two mandibular advancement devices in the treatment of Obstructive Sleep Apnea: a pilot randomized controlled trial. BMC Oral Health. 2024. BMC Oral Health 2024 PubMed
- Al Khouri T, et al. An analysis of adverse events associated with Mandibular Repositioning Appliances (MRA). Respir Med. 2025. Respir Med 2025 PubMed
- Nanda N, et al. Patient Selection for Efficacious Mandibular Advancement Device Therapy in Obstructive Sleep Apnea: An Institutional Outcomes Analysis. Ann Otol Rhinol Laryngol. 2025. Ann Otol Rhinol Laryngol 2025 PubMed
- Paddenberg-Schubert E, et al. Predictors of disease alleviation with mandibular advancement devices in obstructive sleep apnea: a retrospective cohort study. Head Face Med. 2025. Head Face Med 2025 PubMed
- Abruzzi CM, et al. Long-term mandibular advancement appliance therapy for obstructive sleep apnea: Adherence and outcomes over 10 years. J Am Dent Assoc. 2025. J Am Dent Assoc 2025 PubMed
- Liao J, et al. A pilot randomized trial of a novel digital mandibular advancement device with customized lip bumper. BMC Oral Health. 2025. BMC Oral Health 2025 PubMed
- Hamoda MM, et al. Oral Appliances for the Management of OSA: An Updated Review of the Literature. Chest. 2018. Chest 2018 PubMed